bioAffinity Technologies, Inc. (BIAF)

USD 1.04

(1.96%)

Revenue Summary of bioAffinity Technologies, Inc.

  • bioAffinity Technologies, Inc.'s latest annual revenue in 2023 was 2.53 Million USD , up 52627.44% from previous year.
  • bioAffinity Technologies, Inc.'s latest quarterly revenue in 2024 Q2 was 2.39 Million USD , down -0.36% from previous quarter.
  • bioAffinity Technologies, Inc. reported a annual revenue of 4803.00 USD in annual revenue 2022, down 0.0% from previous year.
  • bioAffinity Technologies, Inc. reported a annual revenue of - USD in annual revenue 2021, down 0.0% from previous year.
  • bioAffinity Technologies, Inc. reported a quarterly revenue of 2.4 Million USD for 2024 Q1, up 8.72% from previous quarter.
  • bioAffinity Technologies, Inc. reported a quarterly revenue of 19.73 Thousand USD for 2023 Q2, up 2043.11% from previous quarter.

Annual Revenue Chart of bioAffinity Technologies, Inc. (2023 - 2019)

Historical Annual Revenue of bioAffinity Technologies, Inc. (2023 - 2019)

Year Revenue Revenue Growth
2023 2.53 Million USD 52627.44%
2022 4803.00 USD 0.0%
2021 - USD 0.0%
2020 - USD 0.0%
2019 - USD 0.0%

Peer Revenue Comparison of bioAffinity Technologies, Inc.

Name Revenue Revenue Difference
Bionano Genomics, Inc. 36.11 Million USD 92.988%
Prenetics Global Limited 21.74 Million USD 88.352%
Star Equity Holdings, Inc. 45.78 Million USD 94.469%
CareDx, Inc 280.32 Million USD 99.097%
Exact Sciences Corporation 2.49 Billion USD 99.899%
Exagen Inc. 52.54 Million USD 95.181%
Inotiv, Inc. 572.42 Million USD 99.558%
Guardant Health, Inc. 563.94 Million USD 99.551%
Biodesix, Inc. 49.08 Million USD 94.841%
BioNexus Gene Lab Corp. 9.77 Million USD 74.081%
Precipio, Inc. 15.19 Million USD 83.336%
iSpecimen Inc. 9.92 Million USD 74.492%
Natera, Inc. 1.08 Billion USD 99.766%
Aspira Women's Health Inc. 9.15 Million USD 72.335%
Standard BioTools Inc. 106.34 Million USD 97.618%
23andMe Holding Co. 219.63 Million USD 98.847%
Castle Biosciences, Inc. 219.78 Million USD 98.848%
Personalis, Inc. 73.48 Million USD 96.554%
Aclaris Therapeutics, Inc. 31.24 Million USD 91.896%
Applied DNA Sciences, Inc. 13.36 Million USD 81.055%
OpGen, Inc. 3.41 Million USD 25.914%
T2 Biosystems, Inc. 7.19 Million USD 64.792%
Myriad Genetics, Inc. 678.4 Million USD 99.627%
ICON Public Limited Company 8.12 Billion USD 99.969%
NeoGenomics, Inc. 591.64 Million USD 99.572%
Star Equity Holdings, Inc. 45.78 Million USD 94.469%
IDEXX Laboratories, Inc. 3.66 Billion USD 99.931%
RadNet, Inc. 1.61 Billion USD 99.843%
MDxHealth SA 70.19 Million USD 96.392%
Psychemedics Corporation 22.09 Million USD 88.54%
Illumina, Inc. 4.5 Billion USD 99.944%
Check-Cap Ltd. - USD -Infinity%
Twist Bioscience Corporation 312.97 Million USD 99.191%
DarioHealth Corp. 20.35 Million USD 87.557%
Fulgent Genetics, Inc. 289.21 Million USD 99.124%
Sera Prognostics, Inc. 306 Thousand USD -727.614%
ENDRA Life Sciences Inc. - USD -Infinity%
OPKO Health, Inc. 863.49 Million USD 99.707%
Medpace Holdings, Inc. 1.88 Billion USD 99.866%
Neogen Corporation 924.22 Million USD 99.726%
Intelligent Bio Solutions Inc. 3.11 Million USD 18.616%
Prenetics Global Limited 21.74 Million USD 88.352%
Mainz Biomed B.V. 895.47 Thousand USD -182.809%
Trinity Biotech plc 56.83 Million USD 95.544%
Neuronetics, Inc. 71.34 Million USD 96.45%
Sotera Health Company 1.04 Billion USD 99.759%
bioAffinity Technologies, Inc. 2.53 Million USD 0.0%